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             One of the hallmarks of the adaptive immune 
system is its ability to provide long-term pro-
tection against infection by otherwise lethal 
pathogens. Great eff  orts have been placed into 
understanding the eff  ector mechanisms that are 
capable of preventing diseases caused by infec-
tion. For viral infections, a vast majority of studies 
have focused on the role of CTL and neutraliz-
ing antibody (Ab) responses. A critical impor-
tance of these antiviral eff  ectors in eliminating 
viral pathogens has been manifested by the large 
number of evasion strategies used by viruses to 
subvert detection by CTLs and Abs. In fact, some 
viruses are so effi   cient at preventing detection by 
CTLs and Abs that these eff  ectors are rendered 
incapable of providing protection in an immu-
nized host (  1  ), which is exemplifi  ed by infection 
with HIV-1 and     -herpesvirus (  2, 3  ). Alternative 
means of providing antiviral protection are re-
quired to combat infection by such viruses. 
  HSV-2, one of the most common sexually 
transmitted infections, causes primary infection 
in the genital mucosal epithelial layer and es-
tablishes latency in the sacral ganglia. In the 
mouse model of genital herpes, priming of the 
host with an attenuated thymidine kinase (TK) 
mutant HSV-2 via the intravaginal (ivag) route 
provides lifelong protection against challenge 
with virulent WT HSV-2. Such protection is 
mediated in a CD4 T cell  –  dependent manner 
(  4, 5  ). In contrast, mice defi  cient in immuno-
globulin or CD8 T cells are protected from viru-
lent HSV-2 challenge after ivag immunization 
with TK       HSV-2 virus (  4  –  7  ), suggesting that 
the protection requires CD4 T cells but not 
CTL or Ab responses. However, the precise 
mechanism by which the memory Th1 cells pro-
vide immune protection in the vaginal mucosa 
is unknown. 
  The importance of Th1 eff  ector cells in de-
fense against intracellular bacterial and protozoan 
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  Although the importance of cytotoxic T lymphocytes and neutralizing antibodies for antivi-
ral defense is well known, the antiviral mechanism of Th1 remains unclear. We show that 
Th1 cells mediate noncytolytic antiviral protection independent of direct lysis through local 
secretion of IFN-     after herpes simplex virus (HSV) 2 infection. IFN-     acted on stromal 
cells, but not on hematopoietic cells, to prevent further viral replication and spread 
throughout the vaginal mucosa. Importantly, unlike other known Th1 defense mechanisms, 
this effector function did not require recognition of virally infected cells via MHC class II. 
Instead, recall Th1 response was elicited by MHC class II  +   antigen-presenting cells at the 
site of infection. Dendritic cells (DCs) were not required and only partially suffi  cient to 
induce a recall response from memory Th1 cells. Importantly, DCs and B cells together 
contributed to restimulating memory CD4 T cells to secrete IFN-    . In the absence of both 
DCs and B cells, immunized mice rapidly succumbed to HSV-2 infection and death. Thus, 
these results revealed a distinct mechanism by which memory Th1 cells mediate noncyto-
lytic IFN-      –  dependent antiviral protection after recognition of processed viral antigens by 
local DCs and B cells. 
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infection in mice previously immunized with an attenuated 
TK       HSV-2. Specifi  cally, we investigate the importance of 
the localization of memory Th1 cells, and the eff  ector mole-
cules and cell types involved in mediating Th1 antiviral pro-
tection in the mucosa in response to HSV-2 challenge. 
    RESULTS   
  Memory Th1 cells, but not CD8 T cells, localize 
in the vaginal mucosa and are required for virus clearance 
after HSV-2 secondary challenge 
  Ivag infection of naive mice with the neurovirulent WT 
HSV-2 (186 strain) virus leads to rapid replication in the vag-
inal epithelium followed by paralysis and death within 7  –  8 d 
(  4, 7  ). However, mice previously immunized with an attenuat  ed 
HSV-2 (TK        strain) are protected from secondary challenge 
with the WT 186 strain. To begin to elucidate the mechanism 
by which Th1 memory cells provide protection at the muco-
sal tissue, we examined the localization of CD4 T cells in the 
vaginae of naive and immune mice. In contrast to the scattered 
distribution of CD4 T cells in the vagina of naive mice (  Fig. 
1 A  ), organized clusters of CD4 T cells were evident in the 
vaginal submucosa of mice at 3 wk after immunization with 
TK       HSV-2 (  Fig. 1 B  ).   These CD4 T cells had an activated 
phenotype, as they expressed CD44 and CD11a (unpublished 
data). To examine the migratory ability of these T cell subsets 
to the vaginal mucosa, bulk eff  ector CD4 or CD8 T cells pu-
rifi  ed from the draining LNs of TK       HSV-2  –  primed mice 
were adoptively transferred into congenic hosts. The local-
ization of these cells was tracked by staining for the CD45.1 
congenic marker of the donor T cells in situ. Upon infection 
of the host animals with HSV-2 ivag, only the eff  ector CD4 
and not naive CD4 or eff  ector CD8, T cells were found to 
localize to the vagina (  Fig. 1 C  ). Further analyses revealed that 
these CD4 T cells migrated above the basement membrane 
into the infected epithelial layer (  Fig. 1 D  ). Subsequently, only 
the mice that received eff  ector CD4 and not CD8 T cells 
were able to control viral replication and spread (  Fig. 1 C  ). 
Next, the specifi  city of the migration of memory Th1 cells 
was examined (Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20082039/DC1). Donor mice (CD45.1  +  ) 
were infected ivag with HSV-2 or infl  uenza virus, and the 
migration pattern of bulk eff  ector LN CD4 T cells was fol-
lowed upon adoptive transfer into congenic hosts that were 
infected with either HSV-2 or infl  uenza virus. These analyses 
revealed that eff  ector CD4 T cells migrated into the vaginal 
tissue only in response to homologous and not heterologous 
virus infection (Fig. S1). Thus, memory CD4 T cell migration is 
pathogen specifi  c, and infl  ammatory condition caused by virus 
infection alone is not suffi   cient to recruit nonspecifi  c CD4 T 
cells into the vaginal mucosa. 
  To further dissect the importance of memory CD4 T cells 
in providing protection against the secondary HSV-2 challenge, 
either CD4  +   or CD8  +   cells were depleted by Ab injection in 
HSV-2  –  immune animals before secondary challenge. After Ab 
injection, CD4  +   or CD8  +   T cells were completely depleted 
from the vagina (  Fig. 1 E  ) and elsewhere (not depicted). 
pathogens has been well characterized (  8, 9  ). This process 
primarily involves the activation of infected phagocytes 
through IFN-    , resulting in enhanced phagocytosis and in-
tracellular degradation of bacterial and protozoan pathogens. 
In contrast, the mechanisms by which Th1 memory cells pro-
vide protection against viruses remain much less clear (  10, 11  ). 
There are at least three distinct mechanisms that can account 
for the ability of Th1 cells to mediate antiviral responses. The 
fi  rst is an indirect mechanism where Th1 cells are required 
for providing help to sustain eff  ector CTL and B cells but do 
not themselves play a direct role in clearance of virus in vivo. 
Examples of this type of Th1 function has been seen in West 
Nile virus (  12  ) and infl  uenza virus infections (  13  ). The sec-
ond is the direct lysis of virally infected cells by Th1 killer cells. 
A recent study revealed the importance of antiviral Th1 cells 
in directly recognizing and killing infl  uenza virus  –  infected 
cells through perforin-dependent pathways (  14  ). In this study, 
it was shown that IFN-     secretion by CD4 T cells was not 
required for their antiviral eff  ector function. Direct recogni-
tion and lysis of infected B cells by CD4 T cells also plays an 
important role in control of Epstein Barr virus infection (  15  ). 
A third mechanism involves antiviral function mediated by 
secreted factors. CD4 T cells secrete cytokines such as IFN-     
and TNF, which are known to control viral replication. Such 
a mechanism was shown to mediate viral clearance after the 
transfer of in vitro  –  derived Th1 cell against vesicular stomatitis 
virus (  16  ) and in hepatitis B virus transgenic (Tg) mice (  10  ). 
In the case of genital herpes infection, neutralization of IFN-     
(  5, 17, 18  ) or genetic defi  ciencies in IFN-     (  4  ) render mice 
incapable of suppressing viral replication. However, the pre-
cise mechanism by which Th1 cells are elicited to secrete 
IFN-     during the recall response is unknown. 
  A key question in this regard is whether Th1 cells are 
stimulated to secrete antiviral cytokines by direct recognition 
of virally infected cells through viral antigenic peptides pre-
sented on MHC class II or by an indirect mechanism through 
recognition of local APCs that have taken up viral antigens 
from infected cells. This issue is particularly relevant for infec-
tion by viruses, including HSV-2, that specifi  cally replicate 
within non-APCs, namely, the mucosal epithelial cells (  19  ). 
Most viruses target cells that do not normally express MHC 
class II. Previous studies have shown that in HSV-2  –  primed 
mice, up-regulation of MHC class II on vaginal epithelial cells 
occurs after secondary infection in an IFN-      –  dependent man-
ner (  7, 20  ), raising the possibility that nonprofessional APCs 
could present viral peptides to CD4 T cells directly and be-
come the target of lysis by CD4 killer cells. Because one of the 
hallmarks of IFN-     is its ability to induce MHC class II mole-
cules in professional and nonprofessional APCs, it has been 
assumed that this enables infected cells to directly present viral 
antigens on MHC class II for recognition by Th1 cells. In fact, 
HSV infection leads to inhibition of MHC class II processing 
pathways, suggesting that direct recognition of infected cells 
by CD4 T cells is detrimental to viral spread in the host (  21  ). 
  In this study, we examine the mechanism by which 
memory Th1 cells provide protection against genital HSV-2 JEM VOL. 205, December 22, 2008 
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    Figure 1.         Memory CD4 T cells localize in the vagina of immune mice and provide protection against secondary HSV-2 challenge.  
(A and B) The localization of CD4 and CD8 T cells in the vagina of nonimmunized (A) or TK       HSV-2  –  immunized mice at 3 wk after immunization (B). 
(C and D) Congenic (CD45.1  +  ) effector CD4, CD8, or naive CD4 T cells were adoptively transferred into naive recipient (CD45.2  +  ) mice. At 3 d after ivag 
infection with HSV-2, viral antigen (anti  –  HSV-2, green; C and D), transferred T cells (anti-CD45.1, red; C and D), and MHC class II (blue; D) were visualized. 
Images were captured using a 10 (A  –  C) or 40  ×   (D) objective lens. Arrowheads indicate the basement membrane. Bars, 100   μ  m. (E and F) CD4 or CD8 T cells 
were depleted from TK       HSV-2  –  primed mice and challenged ivag with WT HSV-2. (E) The dot plot represents CD4  +   and  CD8 +   cells in vagina 3 d after 
challenge. (F) Virus titers in the vaginal fl  uids (nonimmune,   n   = 4; immune/control Ab,   n   = 6; immune/anti-CD4,   n   = 4; and immune/anti-CD8,   n   =  4) 
were measured at the indicated days after HSV-2 secondary challenge. Error bars represent the mean   ±   SD of the number of mice per group. These data 
are representative of three similar experiments.     3044 TH1 MEMORY ACTIVATION BY DENDRITIC CELL  S   AND B CELLS   | Iijima et al. 
After challenge with WT HSV-2, virus titers in vaginal wash 
of the mice treated with anti-CD4 Ab were signifi  cantly 
higher than isotype control IgG treated group (  Fig. 1 F  ). 
In fact, the viral titers in the CD4-depleted immune mice 
were comparable to those in the naive animals infected 
with the WT HSV-2 for the fi  rst time, indicating that 
the protection in immune hosts was primarily mediated 
by the CD4 T cells. The anti-CD4 Ab treatment specifi  cally 
depleted CD4 T cells but not CD4  lo   MHC II  +   APCs in the 
vagina (Fig. S2, available at http://www.jem.org/cgi/content/
full/jem.20082039/DC1). This is likely because of higher 
expression of CD4 molecule by the T cells compared with 
APCs (Fig. S2). In contrast, immune mice depleted of CD8 
T cells were protected from secondary viral challenge in a 
manner comparable to that of the intact immunized animals. 
Although somewhat at odds with the study by Parr and Parr 
(  7  ), these data are consistent with other previously published 
studies (  4  –  6, 18  ), which demonstrated that memory Th1 
cells, but not CD8 T cells, play a predominant role in virus 
clearance at the mucosal surface after genital HSV-2 chal-
lenge. This observation correlated with the formation of 
clusters of CD4 T cells, but not CD8 T cells, in the vaginal 
submucosa of the vaginae of immunized host and with the 
selective migration of adoptively transferred Th1 cells, but 
not CTLs, to the site of HSV-2 infection. 
  Direct lytic pathways involving perforin or Fas  –  FasL 
are not required for protection mediated by memory CD4 
T cells after genital HSV-2 challenge 
  Clearance of virus infection by memory Th1 cells can be 
mediated either by direct lysis of infected cells or through a 
noncytolytic pathway. Perforin-mediated cytotoxic mecha-
nisms have been seen in human CD4 T cell lines against 
HSV-infected cells (  22  ), whereas both perforin- and Fas-de-
pendent cell lysis are used by anti  –  HSV-2 CD8 T cells (  23  ). 
To determine the collective requirement of the two major 
mechanisms to directly lyse virally infected cells, namely 
perforin and FasL, we generated BM chimeric mice in which 
lethally irradiated B6.MRL/  lpr   (Fas mutant) mice were 
reconstituted with BM cells isolated from Perforin      /     mice 
(Perforin      /       →    lpr  ). A potential complication of the use 
of the   lpr   mice is the abnormal development of the 
CD4       CD8       B220  +  double negative (DN) T cells leading to 
lymphadenopathy (  24  ). 14 wk after BM transplantation, the 
emergence of the DN T cells in draining LNs was analyzed 
by fl  ow cytometry. Unlike the   lpr   mice (  Fig. 2 A  ), the per-
centages of DN T cells in Perforin      /       →    lpr   chimera were 
comparable to the WT  →  WT and Perforin      /       →  WT chime-
ric mice.   Perforin      /       →    lpr   mice appeared to develop a 
normal T cell compartment devoid of autoreactive cells, 
circumventing problems associated with cell transfer into 
    Figure 2.         Direct cytolysis via perforin or Fas  –  FasL is not required 
for Th1-mediated protection.   C57BL/6 (WT)   → WT  ( n   = 3), Perfo-
rin     /    → WT  ( n   = 4), and Perforin     /    →  lpr   chimera  ( n   = 5) were immu-
nized with TK       HSV-2 ivag and, 3 wk later, challenged with lethal WT 
HSV-2 virus. As a control, nonimmunized C57BL/6 mice were challenged 
with the virus. (A) FACS analyses of CD4 and CD8 expression in live CD3  +  
cells in the peripheral blood of WT   →  WT chimera, Perforin     /    →  lpr   chi-
mera, and   lpr   mice. The percentage of the CD3  + CD4     CD8     B220 +   cells  (DN 
cells) found in these mice is shown in the histogram. (B) Survival, genital 
mean pathology scores, and viral titers in vaginal wash after secondary 
challenge are depicted. Error bars represent the mean   ±   SE of the number 
of mice per group. These results are representative of three similar 
experiments.   
 JEM VOL. 205, December 22, 2008 
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nonlethally irradiated   lpr   mice (  25  ). Consistent with this, we 
observed no splenomegaly or lymphadenopathy in the Perfo-
rin      /       →    lpr   chimera (unpublished data). Thus, Perforin      /       →    lpr   
mice allowed us to examine the collective importance of per-
forin- and Fas-FasL  –  mediated lysis of infected cells by Th1 cells 
in the absence of autoimmunity. TK       HSV-2  –  immunized 
Perforin      /       →     lpr   mice were found to be completely resistant to 
secondary challenge with WT HSV-2 and were protected from 
viral disease in a manner comparable to that of the WT  →  WT 
and Perforin      /       →  WT chimeric mice (  Fig. 2 B  ). These data 
revealed that neither perforin nor Fas  –  FasL pathways were 
required for the Th1-mediated protection against HSV-2 
challenge. 
  Th1-mediated antiviral protection requires IFN-     
responsiveness by the stromal, but not 
the hematopoietic, compartment 
  Having excluded direct cytolysis by perforin and FasL as the 
mechanism of Th1-mediated protection, we focused on the 
noncytolytic mechanism of control of viral replication. First, to 
examine whether IFN-     activity is required for Th1-mediated 
protection, we analyzed the ability of the immunized IFN-   R      /      
mice to control viral replication upon secondary challenge 
with WT HSV-2. Despite the normal development of memory 
Th1 responses (Fig. S3, available at http://www.jem.org/cgi/
content/full/jem.20082039/DC1), immunized IFN-    R      /      
mice were unable to control HSV-2 replication (  Fig. 3 A  ).   In 
contrast, immunized IFN-        R      /      mice quickly cleared the 
HSV-2 virus and were mostly protected from disease (Fig. S4). 
These data showed that the responsiveness to IFN-     is necessary 
for Th1-mediated protection against HSV-2 mucosal infection. 
  Next, to examine the cell types in which IFN-     respon-
siveness is required for Th1-mediated virus clearance, we gen-
erated two sets of BM chimeric mice: IFN-    R      /      BM into 
WT mice (IFN-    R      /       →  WT) and WT BM into IFN-    R      /      
mice (WT  →  IFN-    R      /     ). These mice were immunized ivag 
with TK       HSV-2 and were challenged with WT HSV-2 3 wk 
later. Within 3 d of secondary challenge, WT mice completely 
cleared the virus, whereas the virus titers of IFN-    R      /      re-
mained high, which was similar to the naive WT mice (  Fig. 3 A  ). 
In the IFN-    R      /       →  WT BM chimera, in which only the 
stromal cells were responsive to IFN-    , HSV-2 virus was 
completely cleared. In contrast, in the WT  →  IFN-    R      /      BM 
chimera in which the stromal cells failed to respond to IFN-    , 
HSV-2 titers remained remarkably high, which was similar to 
those of naive mice after primary challenge (  Fig. 3 C  ). Protec-
tion seen in all groups was completely abrogated by the deple-
tion of CD4 T cells at the memory phase (  Fig. 3, B and D  ). 
These data indicated that responsiveness to IFN-     by the stro-
mal, but not hematopoietic, compartment is essential for Th1-
mediated protection against HSV-2. 
  Rapid induction of IFN-      –  mediated MHC class II molecules 
on vaginal epithelial cells after HSV-2 secondary infection 
  Thus far, our data showed the importance of IFN-     respon-
siveness by stromal cells in Th1-mediated protection. However, 
    Figure 3.         Virus clearance mediated by memory CD4 T cells re-
quires IFN-     responsiveness by the stromal, but not the hematopoi-
etic, compartment.   129 (WT;   n   = 9), IFN-   R    /     ( n   = 3), WT  → IFN-  R    /    
(  n   = 6), and IFN-   R    /    →  WT mice (  n   = 6) were immunized with TK      HSV-2 
ivag and, 4 wk later, challenged with lethal WT HSV-2. As a control, 
nonimmunized 129svj mice (  n   = 6) were challenged with WT HSV-2 
(A and C). CD4 T cells were depleted from the respective groups of mice 
before secondary challenge with WT HSV-2 (B and D). Each bar represents 
the mean   ±   SE of the number of mice per group. Viral titers in vaginal 
washes after secondary challenge were measured. These results are repre-
sentative of two similar experiments.     3046 TH1 MEMORY ACTIVATION BY DENDRITIC CELL  S   AND B CELLS   | Iijima et al. 
secretion by memory CD4 T cells (in immune mice) or NK 
cells (in naive mice), respectively (Fig. S7). Inoculation of 
IFN-     at 2 h suppressed viral replication (Fig. S7 A), delayed 
pathology (Fig. S7 B), and reduced mortality (Fig. S7 C). In 
contrast, treatment with IFN-     at 48 h after infection resulted 
in no enhancement in protection from HSV-2 infection. 
These data indicated that an early timing of IFN-     secretion is 
critical in antiviral defense and suggest this as a mechanism for 
protection off  ered by memory CD4 T cells but not NK cells. 
  Direct recognition of viral antigen presented on MHC class 
II by the infected epithelial cells is not required for Th1-
mediated protection 
  Our data indicated that protection against HSV-2 is depen-
dent on CD4 T cells, independent of cytolysis, and requires 
IFN-     responsiveness by stromal cells. The target of viral in-
fection, the vaginal keratinocytes, responds to IFN-     and up-
regulates MHC class II expression. Thus, the most parsimonious 
explanation is that IFN-     secreted by the Th1 cells provides 
protection. Next, we asked whether Th1 cells require direct 
recognition of the viral antigenic peptide presented by the 
MHC class II of the infected vaginal epithelial cells to mediate 
this eff  ect. To this end, we generated BM chimeric mice that 
were capable of expressing MHC class II only by the hemato-
poietic cells. To preserve normal CD4 T cell repertoire in 
such mice, we fi  rst transplanted WT thymus under the kidney 
capsule of MHC class II  –  defi  cient mice to provide a source 
for thymic epithelial cells for positive selection of CD4 T cells. 
These mice were subsequently lethally irradiated and reconsti-
tuted with WT BM cells (WT  →    {  MHC II      /      + WT thy-
mus  }  ). Upon reconstitution (  >  95% reconstituted after 8 wk 
[reference   26  ]), analysis of the peripheral T cells revealed nor-
mal CD4  +   and CD8  +   T cell development in the WT →    {  MHC 
II      /      + WT thymus  }   mice (  Fig. 4 A  ) but, as expected, CD4 
T cells failed to develop in WT  →  MHC II      /      mice without 
the thymic transplantation (Fig. S8, available at http://www
.jem.org/cgi/content/full/jem.20082039/DC1).   Using these 
mice, we examined whether antigen presentation by MHC 
class II on vaginal epithelial cells is critical for the Th1-medi-
ated protection against lethal WT virus challenge. In contrast 
to the immune MHC II      /     mice and WT  →  MHC II      /      mice 
(Fig. S8), immune WT  →    {  MHC II      /      + WT thymus  }   mice 
rapidly and completely eliminated the virus at the site of infec-
tion and were protected from disease upon secondary chal-
lenge with WT HSV-2 (  Fig. 4, B  –  D  ). These data indicated 
that viral antigen presentation on MHC class II molecules by 
the infected vaginal epithelial cells is dispensable for the Th1-
mediated viral clearance. These data also demonstrated that 
the recall activation of memory Th1 cells could be induced by 
the hematopoietic cells, most likely by MHC class II  +   profes-
sional APCs at the mucosal surface. 
  Conventional DCs are not required but are partially 
suffi  cient to induce recall Th1 response 
  Conventional DCs have been shown to be important in ini-
tiating recall CTL response in the LN, draining the sites of 
it is unclear whether the infected epithelial cells themselves can 
present viral antigens on MHC class II. Thus, we examined 
whether vaginal epithelial cells can be induced to express 
MHC class II and whether such expression depends on IFN-    . 
In naive and immune mice, vaginal epithelial cells did not con-
stitutively express MHC class II (Fig. S5, A and C, available at 
http://www.jem.org/cgi/content/full/jem.20082039/DC1). 
However, in immune WT mice, MHC class II was rapidly 
and robustly up-regulated on vaginal epithelial cells after sec-
ondary viral challenge (Fig. S5 D). To examine the IFN-     
dependence of the MHC class II expression, we extended the 
analysis to the vaginal tissues of reinfected immune IFN-   R      /      
and WT  →  IFN-    R      /      chimeric mice. Both of these groups 
of mice (Fig. S5, E and F) failed to express MHC class II on 
the vaginal epithelial cells. Thus, the vaginal epithelial cells, 
the primary target of HSV-2 infection, can express MHC class 
II in an IFN-      –  dependent manner. 
  Secretion of IFN-     by Th1 cells, but not NK cells, 
is suffi  cient for protection against HSV replication 
  Our in vivo fi  ndings indicated that direct IFN-     respon-
siveness by the vaginal stromal cells is required for the 
blockade of virus replication in immunized hosts. Examina-
tion of the vaginal wash at the early stage of secondary chal-
lenge revealed the presence of nanogram per milliliter levels 
of IFN-     (Fig. S6 A, available at http://www.jem.org/cgi/
content/full/jem.20082039/DC1). In primary keratino-
cytes, recombinant IFN-     provided comparable antiviral 
protection as seen with IFN-     (Fig. S6 D). Less than 625 
pg/ml of IFN-     was found to be suffi   cient to completely 
prevent replication of HSV (Fig. S6 C). NK cells did not 
contribute to IFN-     levels in the vaginal mucosa during 
secondary infection (Fig. S6 A). In contrast, rapid induction 
of IFN-     (day 1) after secondary challenge was abrogated 
by anti-CD4 Ab injection (Fig. S6 A). Depletion of both 
CD4 and NK cells resulted in the complete blockade of 
IFN-    . Collectively, these data suggested that in the absence 
of CD4 T cells, mice sustain high levels of viral load in the 
vagina (  Fig. 1 F  ), leading to NK cell stimulation and IFN-     
secretion 2 d after rechallenge. To examine the relative 
abilities of the CD4 and NK cells to provide protection, we 
measured local viral titers in these mice. As shown previ-
ously, depletion of CD4 T cells abrogated antiviral protec-
tion in immune host (Fig. S6 B). In contrast, NK cells were 
not required for protection. These data demonstrated that 
in the absence of CD4 T cells, NK-secreted IFN-     was 
unable to control viral replication. These data indicated that 
local Th1 cells rapidly recognize the virus and secrete IFN-     
within hours of infection (  20  ), which is critical to providing 
protection. In contrast, NK cells failed to confer protection, 
suggesting that IFN-     secreted in the vagina 2 d after rein-
fection is not suffi   cient for virus clearance. To directly test 
the hypothesis that the timing of IFN-     secretion in the va-
gina is crucial in suppression of viral replication, we inocu-
lated naive mice ivag with recombinant IFN-     at either 2 
or 48 h after infection with WT HSV-2 to mimic IFN-     JEM VOL. 205, December 22, 2008 
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secondary infection in response to vesicular stomatitis virus, 
  Listeria monocytogenes  , and infl  uenza virus infections (  27  ). 
To examine whether conventional DCs are required to induce 
recall Th1 responses in the vagina, we generated CD11c  –  diph-
theria toxin (DT) receptor (DTR) Tg BM  →  WT chimeric 
mice (  27  ). Unlike the skin Langerhans cells, the vaginal epi-
thelial DCs, along with the submucosal DCs, were reconsti-
tuted with the donor BM cells ( 26  ). Upon reconstitution, these 
mice were immunized with TK       HSV-2 and, 3 wk later, 
depleted of CD11c  +   DCs by DT inoculation (Fig. S9, available at 
http://www.jem.org/cgi/content/full/jem.20082039/DC1). 
The DT injection regimen led to a near complete   depletion 
of DCs from every organ examined, including the vaginal 
epithelium and lamina propria (  Fig. 5 A  ), without aff  ecting 
the CD11c  lo   T cell populations owing to the low levels of 
CD11c expression by T cells compared with DCs (Fig. S9 E).   
Of note, non-DC MHC class II  +   APCs were still present in 
the DT-treated CD11c-DTR Tg BM  →  WT chimeric mice 
(  Fig. 5 A  ). These APCs consisted of both B cells and mac-
rophages (Fig. S9 E). DC-depleted immune mice were re-
challenged with WT HSV-2 ivag, Th1 cells were enumerated 
by ELISPOT assay (Fig. S10), and viral titers were measured 
from the vaginal washes (  Fig. 5 B  ). These results indicated that 
the absence of DCs aff  ected neither the number of IFN-      –
      secreting cells in the vagina or spleen (Fig. S10) nor the ability of 
Th1 memory cells to mediate antiviral protection (  Fig. 5 B  ). 
  Next, we assessed whether DCs alone are suffi   cient to re-
stimulate memory CD4 T cell response. To this end, we used 
the CD11c/A      b   (Abb) mouse model in which only CD11c  +   
DCs express MHC II (  28  ). Because these mice do not de-
velop CD4 T cells, naive CD4 T cells were adoptively trans-
ferred before immunization (  Fig. 5 C  ). Unlike the skin 
Langerhans cells, which do not express suffi   cient CD11c and 
thus remain MHC II        in Abb mice (  28  ), both the vaginal 
epithelial and submucosal DCs expressed MHC II in Abb 
mice (  Fig. 5 D  ) owing to higher expression of CD11c (  26  ). 
Thus, the use of Abb mice allowed us to examine whether 
vaginal epithelial and submucosal DCs are suffi   cient to in-
duce recall response from memory Th1 cells. As reported 
previously (  19  ), these mice developed normal Th1 response 
upon primary immunization with TK       HSV-2 (  Fig. 5 E  ). 
  However, despite the presence of robust Th1, Abb mice 
had a signifi  cantly delayed clearance of viral load in the va-
gina compared with WT immune mice in which non-DCs 
also expressed MHC II (  Fig. 5 F  ). Thus, collectively, our data 
indicated that the recall response of Th1 memory does not 
require presentation by either keratinocytes or DCs and that 
DCs alone are only partially capable of limiting viral replica-
tion. These results suggested that non-DC local MHC class 
II  +   APCs must cooperate with DCs to induce recall stimula-
tion of memory CD4 T cell response. 
  DCs and B cells maximize memory CD4 T cell response 
and provide protection 
  Finally, we examined the APC populations responsible for 
restimulating Th1 memory during secondary infection with 
    Figure 4.         Direct recognition of the infected vaginal epithelial cells 
by Th1 cells is not required for protection.   C57BL/6 (WT;   n   = 7), MHC 
class II     /     ( n   = 4), WT thymus-transplanted MHC class II     /     BM  chimera, 
and WT  →  { MHC  II    /     + WT thymus  }   (  n   = 9) were immunized with 
TK       HSV-2 ivag and, 4 wk later, challenged with lethal WT HSV-2. As a 
control, nonimmunized C57/BL6 mice (  n   = 6) were challenged with the 
virus. (A) FACS analyses of CD4 and CD8 T cells (live CD3  +   cells) in the 
peripheral blood of C57BL/6 (WT)  →  WT, MHC class II     /    , and WT  →  { MHC 
II     /    + WT thymus  }   mice. (B  –  D) Viral titers in vaginal washes (B), survival (C), 
and genital mean pathology scores (D) after secondary challenge were 
examined. Error bars represent the mean   ±   SE of the number of mice per 
group. These data are representative of three similar experiments.     3048 TH1 MEMORY ACTIVATION BY DENDRITIC CELL  S   AND B CELLS   | Iijima et al. 
    Figure 5.         Conventional DCs are not required but are partially suffi  cient to elicit recall Th1 responses in the vagina.   (A and B) TK      HSV-2-immunized 
CD11c-DTR  →  WT chimeras (  n   = 5) were inoculated with DT or PBS i.p., as shown in Fig. S9 (available at http://www.jem.org/cgi/content/full/jem.20082039/DC1). 
Depletion of vaginal DCs (CD11c  + GFP +   and MHC II  + GFP +  ) in the epithelium and lamina propria after DT injection was examined by FACS analysis (A). Viral titers in 
vaginal secretion were measured at the indicated days after challenge (B). (C  –  F) To examine the suffi  ciency of MHC class II expression on CD11c  +   cells for protection 
against WT HSV-2 secondary challenge, Abb mice and MHC class II     /     mice were transplanted with naive polyclonal CD4 T cells (10  7   cells) 1 d before TK      HSV-2 
immunization (C). MHC class II expression on vaginal DCs in TK       HSV-2  –  immunized mice (4 wk) was analyzed (D). Frozen sections were stained with MHC class II 
(green) and counterstained with DAPI (blue). Images were captured using a 10 (left) or 40  ×   (right) objective. Bars, 100   μ  m. (E) Adoptively transferred naive CD4 T 
cells normally differentiate into Th1 cells in Abb mice immunized with TK       HSV-2. CD4 T cells isolated from the draining LNs of Abb, MHC class II     /     (MHCII    /   ), 
and C57BL6 mice (WT) mice immunized ivag with TK       HSV-2 (7 d after infection) were cocultured with syngeneic splenocytes in the presence of HSV-2 antigens 
(left) or mock antigen (right) and analyzed for IFN-     secretion (in nanograms/milliliter). Each column represents the mean   ±   SD of triplicate samples. (F) 3 wk after 
TK        immunization, Abb and MHC class II     /     mice were challenged with 10  4   PFU WT HSV-2 virus. Viral titers in vaginal secretion were measured at the indicated 
days after challenge. Error bars represent the mean   ±   SD. These data are representative of two similar experiments.    JEM VOL. 205, December 22, 2008 
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of virally infected cells, and a nonlytic mechanism mediated 
by cytokines (  10  ). Our study revealed an important mecha-
nism by which the Th1 cells are elicited to induce IFN-     to 
clear and prevent viral spread, a process which is independent 
of direct recognition of infected cells but involves antigen 
presentation by tissue-resident professional APCs. This path-
way of Th1 recall has several advantages over the other 
HSV-2. To determine which MHC II  +   cells have the poten-
tial to stimulate Th1 cells locally, we analyzed the MHC II  +   
populations from the vaginae of TK       HSV-2  –  immunized 
mice at 3 wk after infection. In addition to DCs, we detected 
both B cells and macrophages in the vaginal tissue of HSV-
2  –  primed mice (Fig. S9, F and G). Based on these fi  ndings, 
we asked if DCs and macrophages or DCs and B cells coop-
erate to activate memory Th1 cells at the site of infection. To 
this end, we fi  rst depleted phagocytes using Clodronate lipo-
some in HSV-immune mice before secondary challenge. 
However, despite the signifi  cant reduction in both the mac-
rophages and DC numbers in the vaginal tissue, this treat-
ment did not result in the loss of protection upon HSV-2 
challenge (Fig. S11). Next, we depleted both DCs and B cells 
in HSV-2  –  immunized CD11c-DTR chimeric mice by treat-
ment with DT (to deplete DCs) combined with injection of 
anti-CD20 Ab to deplete B cells (  29  ). These treatments re-
sulted in a signifi  cant reduction of the number of both DCs 
and B cells (  Fig. 6 A   and Fig. S9).   Mice depleted of either 
DCs or B cells alone were completely protected from sec-
ondary HSV-2 challenge. However, importantly, depletion 
of DCs and B cells from immune mice abrogated Th1-medi-
ated protection (  Fig. 6 B  ). Because epithelial cells, and not 
APCs, were the only cells productively infected by HSV-2 
(Fig. S12), these data suggested that uninfected DCs and B 
cells acquire viral antigens from infected epithelial cells and 
present them to local virus specifi  c CD4 T cells. Collectively, 
these results demonstrated that DCs and B cells are both re-
quired to maximizing Th1 memory responses in vivo. 
    DISCUSSION   
  Our results provide evidence for a mechanism by which 
memory Th1 cells mediate antiviral activity through secre-
tion of IFN-     after activation by local tissue-resident APCs 
(Fig. S13, available at http://www.jem.org/cgi/content/
full/jem.20082039/DC1). In the case of genital herpes infec-
tion, the eff  ector function of memory Th1 cells did not in-
volve direct cytolysis by FasL or perforin. Furthermore, Th1 
memory response did not require direct recognition of the 
infected vaginal epithelial cells via viral antigens presented on 
MHC class II. Instead, the main eff   ector function of the 
memory Th1 cells was mediated by IFN-    , which acted on 
the stromal cells of the vagina, particularly on the vaginal epi-
thelial cells. In contrast, activation of hematopoietic cells by 
IFN-     was dispensable for Th1-mediated protection. Finally, 
although IFN-     secretion by memory Th1 cells in the vagina 
was elicited by hematopoietic cells, conventional DCs were 
neither required nor suffi   cient to fully recall responses at the 
local tissue. Instead, both DCs and B cells presented viral an-
tigens to Th1 cells in the vaginal mucosa and restimulated 
memory Th1 cells during secondary viral challenge. These 
data revealed an important mechanism by which memory 
Th1 cells are elicited by tissue-resident noninfected APCs to 
provide disseminated antiviral protection through IFN-    . 
  Currently, the known antiviral mechanisms of Th1 cells 
include providing help to sustain CTL and B cells, direct lysis 
    Figure 6.         DCs and B cells mediate memory Th1 recall response in 
the vagina.   In addition to depletion of DCs, TK      HSV-2 – immunized 
CD11c-DTR  →  WT chimeras (  n   = 5) were inoculated with either a control 
Ab or anti  –  mouse CD20 i.v., as shown in Fig. S9 (available at http://www
.jem.org/cgi/content/full/jem.20082039/DC1). B cell depletion in the vagi-
nal tissue of TK       HSV-2  –  immunized mice (3 wk after infection) after Ab 
injection was determined by FACS analysis (A). The mortality and mean 
clinical score are shown in B. Error bars represent the mean   ±   SD 
of fi  ve mice per group. These data are representative of three 
similar  experiments.   3050 TH1 MEMORY ACTIVATION BY DENDRITIC CELL  S   AND B CELLS   | Iijima et al. 
vide cognate help to memory Th1 cells. In addition, because 
of the antigen specifi  city provided by memory B cells, they 
may constitute   “  memory APCs.  ”   Future studies to determine 
whether memory B cells provide help to T helper cells dur-
ing secondary infection through BCR-specifi  c uptake of an-
tigens will likely yield new insights. 
  In summary, our results provide evidence for an impor-
tant mechanism by which memory Th1 cells mediate antivi-
ral protection. Because the memory Th1 cells did not require 
direct recognition of viral antigens presented by the infected 
cells via MHC class II, particularly for viruses that encode 
evasion molecules to avoid recognition by the adaptive im-
mune cells, eliciting Th1 memory response might represent 
an ideal vaccine approach. In addition, depending on the 
mode of protection, mobilizing local DCs and B cells to re-
stimulate memory CD4 T cells may be benefi  cial in eliminat-
ing viral pathogens in chronically infected host. 
  MATERIALS AND METHODS 
  Mice.     6  –  8-wk-old female C57BL/6 (CD45.2  +  ), congenic C57BL6 mice, 
B6.SJL-PtprcaPep3b/BoyJ (B6.Ly5.1; CD45.1  +  ), and 129/svJ were pur-
chased from the National Cancer Institute and the Jackson Laboratory. 
B6.129-  H2  dlAb1-Ea    /J (MHC class II      /     ), B6.MRL-  Fas  lpr    /J (B6.MRL/  lpr  ), 
C57BL/6-  Prf  1  tm1Sd      z    /J (Perforin      /     ), and CD11c-DTR Tg mice (B6.FVB-
Tg [Itgax-DTR/GFP] 57Lan/J) were obtained from the Jackson Labora-
tory. IFN-    R      /      and IFN-        R      /      mice (  36  ) on a 129S2 background were 
provided by H.W. Virgin IV (Washington University, St. Louis, MO). 
CD11c/A      b   (Abb) mice have been described previously (  28  ). All procedures 
used in this study complied with federal guidelines and institutional policies 
by the Yale animal care and use committee. 
  Viruses.     186syn       TK        (  37  ) and 186syn  +   (  38  ) were gifts of D. Knipe (Har-
vard Medical School, Boston, MA). HSV-1 KOS VP26-GFP (HSV-1/GFP) 
(  39  ) was a gift from P. Desai and S. Person (John  ’  s Hopkins University, Bal-
timore, MD). HSV-2 was propagated and titered on Vero cells as previously 
described (  19  ). Infl  uenza virus A/PuertoRico/3/334 (A/PR8; H1N1) was a 
gift from H. Hasegawa (National Institute of Infectious Diseases, Tokyo, 
Japan) and was propagated in 10-d fertile chicken eggs and titered on the 
Madin-Darby canine kidney cells (  40  ). 
  Antibodies.     Anti-CD3     (145-2C11), anti-CD45.2 (104), anti-CD45.1 
(A20), anti-CD4 (GK1.5 and RM4-4), and anti –  MHC class II (M5/114.15.2) 
were purchased from eBioscience. Anti-CD8     (53  –  6.7) and anti-CD45R/
B220 (RA3-6B2) were purchased from BD. Anti-CD68 (FA-11) was ob-
tained from AbD Serotec. 
  Flow cytometry.    The DCs and lymphocytes from vaginal epithelia and lamina 
propria were isolated and analyzed as previously described (  26  ) (Supplemental 
materials and methods, available at http://www.jem.org/cgi/content/full/
jem.20082039/DC1). Single-cell suspensions from spleen, draining LNs (ingui-
nal LN and iliac LNs), and vagina were pretreated with anti-Fc receptor Ab 
(eBioscience) at 4  °  C for 10 min. These cells were stained with various antibod-
ies at 4  °  C for 15 min. 7-amino-actinomycin   d   (7-AAD; BD) was added to the 
cells immediately before analysis and 7-AAD  +   dead cells were excluded from 
analysis. Multiparameter analyses were performed on a fl  ow cytometer (LSR II; 
BD) and were analyzed using FlowJo software (Tree Star, Inc.). 
  Construction of BM chimeric mice.     BM chimeric mice using C57BL/6, 
MHC class II      /     , B6.MRL/  lpr  , and Perforin      /      mice were constructed by a 
standard method (  26  ). Irradiated recipient mice were reconstituted with 5   ×   10  6   
cells of the appropriate cell suspension by means of i.v. injection. To generate 
BM chimeric mice using 129/svJ and IFN-    R      /      mice, the recipient mice 
were irradiated with 925 rads and then reconstituted with 1   ×   10  7   cells from 
mechanisms. First, this mode of restimulation cannot be in-
hibited by virally encoded genes that prevent antigen presen-
tation on MHC class II in the infected cells. Second, the 
antiviral eff  ects can be quickly disseminated to a wide range 
of target cells in a given tissue, allowing rapid and complete 
antiviral state to be established in the susceptible mucosa. 
Third, because of the nonlytic nature of the protection, tissue 
injury and viral spread caused by the release of virions from 
lysed cells can be avoided. Finally, this mode of Th1 eff  ector 
function represents an eff  ective means of antiviral protection 
against viruses that do not infect MHC class II  +   APCs. In 
fact, several previous studies have implicated that Th1-medi-
ated antiviral protection can occur indirectly for viruses that 
infect MHC class II        target cells (  13, 30, 31  ). Because only a 
handful of viruses actively target and replicate in professional 
APCs, such means of protection can be exploited for vaccine 
purposes. 
  Our data revealed that IFN-     responsiveness by the he-
matopoietic cells was not required for protection. A similar 
observation was reported recently for CD8-mediated protec-
tion against HSV infection (  31  ). More recently, eff  ector CD4 
T cells were shown to be involved in clearance of HSV-1 
from the neuronal tissues in a manner independent of Fas or 
perforin (  32  ). Our results ruled out the need for DCs, mac-
rophages,          T cells, NK cells, NK T cells, or Th1 cells 
themselves to be restimulated through the IFN-    R to elicit 
or mediate the recall responses. Because macrophage activa-
tion by IFN-     plays a critical role in antibacterial and anti-
protozoan responses, these fi  ndings highlight the diff  erent 
mode of action by which Th1 cells provide immunity to di-
verse sets of pathogens. In addition, these results imply that 
IFN-      –  mediated up-regulation of MHC class II genes on 
tissue-resident APCs is also not required for the induction of 
local recall Th1 responses and suggest that recall response is 
suffi   ciently mediated by non-DC APCs that have constitu-
tive expression of MHC class II. It is unclear what IFN-      –
    induced genes are responsible for the suppression of viral 
replication in the vaginal epithelial cells. At the innate stage, 
antiviral protection conferred by type I IFNs is in part medi-
ated by protein kinase R (  33  ) but not the RNaseL (  34  ) path-
ways. Identifi   cation of the IFN-      –  inducible eff  ectors  that 
can suppress HSV-2 replication will be an important future 
endeavor. In hepatitis B virus Tg mice, transferred virus-spe-
cifi  c Th1 cells secreted antiviral cytokines by recognizing an-
tigen presented by nonparenchymal cells (  10  ). However, the 
type or origin of such APCs remains unknown. Our data 
demonstrated that local DCs and B cells stimulate memory 
Th1 cells during secondary viral challenge. This is in contrast 
to the selective requirement for DCs in memory CD8 T cell 
activation (  27  ) and highlights the distinct cellular subsets in-
volved in memory CD8 versus CD4 T cell recall responses. 
B cells and DCs have been shown to contribute to priming 
of CD4 T cell response during   L. monocytogenes   infection 
(  35  ). It is interesting to speculate that because of the ability of 
B cells to selectively take up viral antigens through their B 
cell receptors, these cells may become potent APCs and pro-JEM VOL. 205, December 22, 2008 
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viously described procedure (  19  ). Likewise, HSV-2 and CD45.1 antigens 
were detected using biotin-conjugated anti  –  mouse CD45.1 Ab and FITC-
conjugated mAbs anti-HSV 1 and 2, respectively, which are specifi  c for en-
velope glycoprotein (ViroStat). Stained slides were washed and incubated 
with DAPI and mounted with Fluoromount-G (SouthernBiotech). These 
slides were analyzed by fl  uorescence microscopy (BX51; Olympus). 
  Online supplemental material.     Fig. S1 shows the antigen specifi  city of 
migration of Th1 cells after viral challenge into the vaginal tissue. Fig. S2 
shows the depletion of CD4  +   T cells, but not APCs, upon anti-CD4 Ab 
treatment. Fig. S3 shows Th1 response in draining LNs in WT or IFN-
    R      /      mice after TK        immunization for 3 wk. Fig. S4 shows HSV-2 titer 
and clinical score of WT and IFN-        R      /      mice after HSV-2 secondary 
challenge. Fig. S5 shows up-regulation of MHC class II mediated by IFN-     
signaling on vaginal epithelial cells after secondary HSV-2 challenge. Fig. S6 
shows IFN-     secretion in vaginal wash of TK       HSV-2  –  immunized mice 
after secondary challenge, treated with anti-CD4 Ab and/or anti-NK1.1 
Ab, and the eff  ect of IFN-     or IFN-     on the protection of primary ke-
ratinocytes against in vitro HSV-2 infection. Fig. S7 shows the eff  ective-
ness of topically applied recombinant IFN-     in preventing viral replication 
and viral disease after lethal WT HSV-2 challenge. Fig. S8 shows a lack 
of protection in TK       HSV-2  –  immunized WT into MHC class II      /      BM 
chimera after secondary challenge. Fig. S9 shows DT injection scheme and 
the effi   cacy of CD11c  +   cell and B cell depletion, but not memory Th1 
cells, in vagina, spleen, and draining LNs. It also demonstrates APC popula-
tions in the vagina of HSV-2  –  primed mice. Fig. S10 shows the enumera-
tion of HSV-2  –  specifi  c Th1 response in vagina of TK       HSV-2  –  immunized 
mice with or without DC depletion. Fig. S11 shows HSV-2  –  infected cells 
in the vagina of nonimmune mice. Fig. S12 shows that HSV-2 predomi-
nantly infects epithelial cells and not APCs. Fig. S13 shows a schematic 
representation of memory Th1 cell  –  mediated antiviral immunity in mu-
cosal tissues. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20082039/DC1. 
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BM as previously reported (  41  ). The reconstituted mice were maintained in a 
clean facility for at least 8 wk before use. 
  Immunization and viral challenge.     Female mice were injected s.c. in the 
neck ruff   with progesterone (Depo Provera; GE Healthcare) at 2 mg per mouse 
in a 100-  μ  l volume. These mice were immunized ivag with 10  6   PFU HSV-2 
(186syn        and TK       ) in a 10-  μ  l volume. At 3  –  4 wk later, immunized mice were 
challenged with 10  4   PFU HSV-2 (186syn  +  ) ivag using a previously described 
protocol (  5  ). The severity of disease was scored as follows (  42  ): 0, no sign; 1, 
slight genital erythema and edema; 2, moderate genital infl  ammation; 3, puru-
lent genital lesions; 4, hindlimb paralysis; and 5, premoribund. Because of hu-
mane concerns, the animals were killed before reaching the moribund state. 
  DT-mediated DC depletion.     For systemic DC depletion in vivo, CD11c-
DTR  →  WT BM chimeras were inoculated ivag with 320 ng DT (Sigma-Aldrich) 
daily between days     6 and     1 by i.p. injection of WT virus challenge. Depletion 
of CD11c  +   cells was assessed by FACS of splenocytes and vaginal leukocytes. 
  In vivo depletion of lymphocytes.     Depletion of CD4 or CD8 T cells were 
performed at days     5,     3, and     1 and 1, 3, and 5 after rechallenge by i.p injec-
tion of 400   μ  g of anti-CD4 (GK1.5; rat IgG2b) or anti-CD8 (53  –  6.72; rat 
IgG2a) Abs. Control mice were injected with 400   μ  g of rat IgG. In vivo deple-
tion was confi  rmed by FACS analysis of the cell suspension from secondary 
lymphoid organs and vaginae of the Ab-treated mice at 4 d after secondary chal-
lenge. For NK cell depletion, purifi  ed anti  –  mouse NK1.1 (PK136; eBioscience) 
was given an i.p. injection of 200   μ  g Ab in PBS 2 d before and 1 d after challenge 
as previously reported (  43  ). For B cell depletion, 250   μ  g of purifi  ed anti  –  mouse 
CD20 (18B12; mouse IgG2a) or anti  –  human CD20 Ab (2B8; mouse IgG2a) in 
PBS was given via i.v. injection at 4 and 8 d before challenge (  29  ). For phagocyte 
depletion in blood and vagina, clodronate liposome or PBS liposome (250   μ  l for 
i.v. and 10   μ  l for ivag) were injected at 4 and 1 d before challenge. These lipo-
somes were a gift from Roche and were generated as previously described (  44  ). 
  Vaginal viral titers and cytokine measurement.     Vaginal fl  uids were col-
lected on days 1  –  7 after infection using calcium alginate swabs and PBS. Viral 
titers were obtained by titration of vaginal wash samples on Vero cell mono-
layer as described previously (  19  ). IFN-     and IFN-     were detected in vaginal 
fl  uids by ELISA as previously described (  45  ). 
  Adoptive transfer of naive or eff  ector T cells.     For preparation of naive 
CD4, eff  ector CD4, and eff  ector CD8 T cells for adoptive transfer, congenic 
C57BL/6 (CD45.1  +  ) mice were inoculated ivag with mock, TK       HSV-2 (1  ×   10  6   
PFU/mouse), or infl  uenza virus A/PR8 (3   ×   10  5   PFU/mouse) for 7 d (  46  ). 
CD4 and CD8 T cells were purifi  ed using a MACS column (Miltenyi Biotec). 
The selected CD4  +   or CD8  +   T cells (  >  90% purity) were used for adoptive 
transfer. Six to ten million purifi  ed cells were transferred i.v. into the CD45.2  +   
C57BL/6 recipient. 2 h after transfer, these recipients were challenged with 10  4   
PFU WT HSV-2 virus or 1   ×   10  6   PFU of infl  uenza virus A/PR/8. Vaginae 
were harvested at 3 d after virus infection and were processed and analyzed by 
immunofl  uorescence staining as described in Immunofl  uorescence staining. 
  Thymic transplantation.     The thoracic cavity of neonatal B6 pups (  <  2 d 
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